Other studies on OSCC and lung adenocarcinoma cells observed that enoxaparin works to reduce tumour proliferation and migration via interference of PI3k/Akt and MAPK/ERK signalling pathways [8,23]. This evidence concerns the gene AKT1 and lung adenocarcinoma.